EUVIMEDEUVIMED entdecken
Open Access

PINK1-mediated mitophagy supports lung cancer initiation and limits the efficacy of KRAS -targeted therapy

Diogo Gonçalves iD, Emma Guilbaud iD, Léa Di Mascio iD, Camille Guerrier iD, Linda Mejri, Sonia Núñez-Vázquez iD, Lucie Levasseur, Rachel Paul iD, Corinne Menigot iD, Christophe Bontoux iD, Guylène Rignol, Véronique Hofman iD und 7 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aef8820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Diogo Gonçalves und 18 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, INSERM, C3M, Nice, France. Hauptthemen laut MEDLINE: Mitophagy, Lung Neoplasms, Proto-Oncogene Proteins p21(ras), Protein Kinases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Agence Nationale de la Recherche, Fondation pour la Recherche Médicale, Institut National Du Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitophagy, the selective degradation of mitochondria by lysosomes, is a major mitochondrial quality-control pathway, yet its role in lung cancer initiation and therapeutic response remains poorly understood. We investigated PINK1-dependent mitophagy in human lung adenocarcinoma and directly monitored mitophagy in vivo using mito-QC reporter mice during lung tumor development. We found that PINK1 activity and mitophagy are increased in human tumors and are activated from the earliest stages of tumorigenesis. Genetic inhibition of PINK1 impaired oncogenic transformation but had little impact once tumor cells were established, identifying mitophagy as a critical early adaptation during lung cancer initiation. PINK1 deficiency markedly enhanced the efficacy of KRAS -targeted therapy in vitro and in vivo. Together, our findings identify PINK1-dependent mitophagy as an early vulnerability in KRAS -driven lung cancer and provide a rationale for targeting mitophagy to improve the efficacy of KRAS -targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyLung NeoplasmsProto-Oncogene Proteins p21(ras)Protein KinasesHumansAnimalsPTEN-Induced Putative KinaseMiceMitochondriaCell Line, TumorMolecular Targeted TherapyCell Transformation, Neoplastic

Substanzen

PTEN-Induced Putative KinaseProto-Oncogene Proteins p21(ras)Protein KinasesKRAS protein, human

Autor:innen und Institutionen

  • Université Côte d'Azur, INSERM, C3M, Nice, France.
  • Équipe labellisée LIGUE Contre le Cancer, Nice, France.
  • IHURespirERA, FHU OncoAge, Nice, France.
  • Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Department of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, 1 av Irène Joliot-Curie, Toulouse, 31059, France.
  • Université Côte d'Azur, INSERM, CNRS, IRCAN, Nice, France.

ORCID-Profile: Diogo Gonçalves, Emma Guilbaud, Léa Di Mascio, Camille Guerrier, Sonia Núñez-Vázquez, Rachel Paul, Corinne Menigot, Christophe Bontoux, Véronique Hofman, Paul Hofman, Marin Truchi, Bernard Mari, Laurent Yvan-Charvet, Johanna Chiche, Sandrine Marchetti, Jean-Ehrland Ricci

Förderung

  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale
  • Institut National Du Cancer
  • AACR
  • Eileen Stein Jacoby Fund
  • la Ligue Nationale Contre le Cancer “Équipe Labellisée LIGUE”
  • Conseil Général CG06
  • Conseil Régional PACA

Zitieren

APA

Gonçalves, D., Guilbaud, E., Di Mascio, L., Guerrier, C., Mejri, L., Núñez-Vázquez, S., Levasseur, L., Paul, R., Menigot, C., Bontoux, C., Rignol, G., Hofman, V., Hofman, P., Truchi, M., Mari, B., Yvan-Charvet, L., Chiche, J., Marchetti, S., & Ricci, J. E. (2026). PINK1-mediated mitophagy supports lung cancer initiation and limits the efficacy of KRAS -targeted therapy. Science Advances. https://doi.org/10.1126/sciadv.aef8820

Vancouver

Gonçalves D, Guilbaud E, Di Mascio L, Guerrier C, Mejri L, Núñez-Vázquez S, et al. PINK1-mediated mitophagy supports lung cancer initiation and limits the efficacy of KRAS -targeted therapy. Science Advances. 2026. doi:10.1126/sciadv.aef8820

BibTeX
@article{Gonalves2026,
  author = {Gonçalves, Diogo and Guilbaud, Emma and Di Mascio, Léa and Guerrier, Camille and Mejri, Linda and Núñez-Vázquez, Sonia and Levasseur, Lucie and Paul, Rachel and Menigot, Corinne and Bontoux, Christophe and Rignol, Guylène and Hofman, Véronique and Hofman, Paul and Truchi, Marin and Mari, Bernard and Yvan-Charvet, Laurent and Chiche, Johanna and Marchetti, Sandrine and Ricci, Jean-Ehrland},
  title = {PINK1-mediated mitophagy supports lung cancer initiation and limits the efficacy of KRAS -targeted therapy},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aef8820}
}
Kostenlos starten →